Live Breaking News & Updates on Squibb Institute|Page 2

Stay updated with breaking news from Squibb institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bristol Myers Squibb Announces Dividend

Bristol Myers Squibb today announced that its Board of Directors has declared a quarterly dividend of fifty-seven cents per share on the $0.10 par value common stock of the company. The dividend is. | June 14, 2023 ....

Bristol Myers Squibb , Bristol Myers Squibb Company , Myers Squibb , Bristol Myers Squibb Company Stock Exchange , Press Release , Ividend Bmy Us1101221083 ,

Bristol Myers Squibb Facility Gets Commercial Production Approval From FDA

By Denny Jacob

Bristol Myers Squibb on Thursday said commercial production at its cell therapy manufacturing facility received U.S. Food and Drug Administration approval.

The. | June 8, 2023 ....

Denny Jacob , Bristol Myers Squibb , Drug Administration , Myers Squibb , Dow Jones , Bristol Myers Squibb Company Stock Exchange , Press Release , Dministration Bmy Us1101221083 ,

Bristol Myers Squibb to Participate in Upcoming Investor Conferences

Bristol Myers Squibb today announced that the company will participate in the following investor conferences in June 2023:

Company executives will take part in a fireside chat at the 2023. | June 1, 2023 ....

New York , United States , Dana Point , Bristol Myers Squibb , Goldman Sachs , Healthcare Conference , Myers Squibb , Annual Global Healthcare Conference , Bristol Myers Squibb Company Stock Exchange , Press Release , He Bmy Us1101221083 ,

Bristol Myers Squibb to Hold R&D Day on September 14

Bristol Myers Squibb today announced that the company will hold a Research & Development Day in New York City on Thursday, September 14, 2023, at 9:00 a.m. Company executives will provide. | May 31, 2023 ....

Bristol Myers Squibb , Research Development Rd Day , Bristol Myers Squibb Company , New York City , Myers Squibb , Bristol Myers Squibb Company Stock Exchange , Press Release , Ill Bmy Us1101221083 ,

Bristol Myers Gets FDA Priority Review of Repotrectinib in Certain Non-Small Cell Lung Cancer

By Colin Kellaher

Bristol Myers Squibb on Tuesday said the Food and Drug Administration granted priority review to its application seeking approval of repotrectinib for certain patients with. | May 30, 2023 ....

New York , United States , Bristol Myers , Bristol Myers Squibb , Colin Kellaher , Drug Administration , Myers Squibb , Turning Point Therapeutics , Dow Jones , Bristol Myers Squibb Company Stock Exchange , Press Release , Atients Bmy Us1101221083 ,